Algeta U.S. celebrates official opening of operational center in Cambridge, MA
September 18, 2012
From left to right: Celebrating the opening of Algeta U.S.’ new offices in Cambridge, Massachusetts are Philina Lee, Director, U.S. Marketing, Algeta U.S.; Oystein Soug, CFO, Algeta ASA; Jeff Albers, President, Algeta U.S.; Lt. Gov. Timothy Murray; State Representative Timothy Toomey (D-Cambridge); Susan Windham-Bannister, Ph.D., President & CEO, Massachusetts Life Sciences Center; Peter Abair, Director, Economic Development & Global Affairs, MassBio; Tom Klima, National Sales Director, Algeta U.S.; Khalid Mamlouk, Sr. Director, U.S. Medical Affairs, Algeta U.S.
On Tuesday, September 18th, 2012, Algeta ASA, a Norway-based company focused on the development of novel targeted cancer therapeutics, celebrated the official opening of the offices and facilities of Algeta US in Cambridge, Massachusetts.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.